Morgan Stanley

13F Holdings History for WEX Inc. - Common Stock, $0.01 par value per share (WEX)

Symbol: WEX on NYSE
Investment type: Equity / Common Stock, $0.01 par value per share
Latest Disclosed Ownership: 2.42M shares
Security Ownership: 7.1%

Shares, Excluding Options vs Price

Value, Excluding Options

Morgan Stanley ownership in WEX Inc. Common Stock, $0.01 par value per share (WEX)

2025-05-07 - Morgan Stanley has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2.42M shares of WEX Inc. Common Stock, $0.01 par value per share (WEX). This represents 7.1% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Morgan Stanley	7.1%		$322M	2.42M			$133.05	13G/A	3/31/2025	7 May 2025 11:10:35

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0.03%	+0%	$430M	2.73M	+47,751	+1.78%	$157.53	Q3 2025
6/30/2025	0.03%	+0%	$394M	2.68M	+244,285	+10%	$146.89	Q2 2025
3/31/2025	0.03%	+0%	$383M	2.44M	+242,342		$157.02	Q1 2025
12/31/2024	0.03%	0%	$385M	2.2M	-70,696		$175.32	Q4 2024
9/30/2024	0.03%	+0%	$476M	2.27M	+68,267		$209.73	Q3 2024
6/30/2024	0.03%	+0%	$390M	2.2M	+243,537		$177.14	Q2 2024
3/31/2024	0.04%		$465M	1.96M			$237.53	Q1 2024
12/31/2023	0.03%		$313	1			$313.00^*	Q4 2023
12/31/2023	0.03%		$373M	1.92M			$194.55	Q4 2023
9/30/2023	0.04%	0%	$350M	1.86M	-37,222	-1.96%	$188.09	Q3 2023
6/30/2023	0.03%	0%	$346M	1.9M	-199,244	-9.5%	$182.07	Q2 2023
3/31/2023	0.04%	+0%	$386M	2.1M	+38,390	+1.86%	$183.89	Q1 2023
12/31/2022	0.04%	+0.03%	$337M	2.06M	+1,594,294	+342%	$163.65	Q4 2022
9/30/2022	0.01%	0%	$59.1M	466K	-36,108	-7.2%	$126.94	Q3 2022
6/30/2022	0.01%	+0.01%	$78M	502K	+302,089	+151%	$155.56	Q2 2022
3/31/2022	0%	+0%	$35.6M	200K	+1,071	+0.54%	$178.45	Q1 2022
12/31/2021	0%	0%	$27.9M	199K	-55,654	-21.9%	$140.39	Q4 2021
9/30/2021	0.01%	0%	$44.8M	254K	-40,715	-13.8%	$176.14	Q3 2021
6/30/2021	0.01%	+0%	$57.2M	295K	+129,958	+78.8%	$193.90	Q2 2021
3/31/2021	0.01%	0%	$34.5M	165K	-69,035	-29.5%	$209.22	Q1 2021
12/31/2020	0.01%	+0%	$47.6M	234K	+34,468	+17.3%	$203.53	Q4 2020
9/30/2020	0.01%	+0%	$27.7M	200K	+162,899	+445%	$138.97	Q3 2020
6/30/2020	0%	0%	$6.04M	36.6K	-33,588	-47.8%	$164.99	Q2 2020
3/31/2020	0%	+0%	$7.34M	70.2K	+17,793	+33.9%	$104.54^*	Q1 2020
12/31/2019	0%	+0%	$11M	52.4K	+16,933	+47.7%	$209.48	Q4 2019
9/30/2019	0%	0%	$7.17M	35.5K	-1,347	-3.66%	$202.04	Q3 2019
6/30/2019	0%	+0%	$7.67M	36.8K	+5,040	+15.9%	$208.09	Q2 2019
3/31/2019	0%	-0.01%	$6.11M	31.8K	-180,316	-85%	$192.01	Q1 2019
12/31/2018	0.01%	+0.01%	$29.7M	212K	+143,284	+208%	$140.06	Q4 2018
9/30/2018	0%	+0%	$13.8M	68.8K	+20,040	+41.1%	$200.76	Q3 2018
6/30/2018	0%	0%	$9.29M	48.8K	-29,511	-37.7%	$190.48	Q2 2018
3/31/2018	0%	+0%	$12.3M	78.3K	+7,308	+10.3%	$156.61	Q1 2018
12/31/2017	0%	0%	$10M	71K	-16,065	-18.5%	$141.22	Q4 2017
9/30/2017	0%	+0%	$9.77M	87.1K	+33,745	+63.3%	$112.22	Q3 2017
6/30/2017	0%	0%	$5.56M	53.3K	-20,989	-28.2%	$104.26	Q2 2017
3/31/2017	0%	+0%	$7.69M	74.3K	+16,876	+29.4%	$103.50	Q1 2017
12/31/2016	0%	+0%	$6.41M	57.4K	+23,032	+67%	$111.59	Q4 2016
9/30/2016	0%	+0%	$3.72M	34.4K	+3,520	+11.4%	$108.08	Q3 2016
6/30/2016	0%	+0%	$2.74M	30.9K	+24,178	+361%	$88.69	Q2 2016
3/31/2016	0%	0%	$559K	6.69K	-10,189	-60.4%	$83.52^*	Q1 2016
12/31/2015	0%	0%	$1.49M	16.9K	-33,508	-66.5%	$88.44	Q4 2015
9/30/2015	0%	0%	$4.38M	50.4K	-10,168	-16.8%	$86.84^*	Q3 2015
6/30/2015	0%	+0%	$6.9M	60.6K	+12,269	+25.4%	$113.97	Q2 2015
3/31/2015	0%	0%	$5.18M	48.3K	-88,321	-64.7%	$107.35	Q1 2015
12/31/2014	0%	+0%	$13.5M	137K	+111,996	+455%	$98.92	Q4 2014
9/30/2014	0%	+0%	$2.72M	24.6K	+14,014	+132%	$110.30	Q3 2014
6/30/2014	0%	0%	$1.11M	10.6K	-21,149	-66.6%	$104.91	Q2 2014
3/31/2014	0%	+0%	$3.02M	31.7K	+7,960	+33.5%	$95.09	Q1 2014
12/31/2013	0%		$2.36M	23.8K			$99.00	Q4 2013

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.